Pages that link to "Q35716914"
Jump to navigation
Jump to search
The following pages link to Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States (Q35716914):
Displaying 47 items.
- Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis (Q28360623) (← links)
- Mechanisms of action of 5-fluorocytosine (Q28366384) (← links)
- Epidemiology of invasive candidiasis: a persistent public health problem (Q29616758) (← links)
- The ins and outs of DNA fingerprinting the infectious fungi (Q33555593) (← links)
- A Candida albicans dispersed, repeated gene family and its epidemiologic applications (Q33556333) (← links)
- Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group (Q33684486) (← links)
- Complementation analysis of resistance to 5-fluorocytosine in Candida albicans (Q33738111) (← links)
- Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance (Q33749111) (← links)
- In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. (Q34142406) (← links)
- High-frequency switching in Candida albicans (Q34402581) (← links)
- Flucytosine resistance is restricted to a single genetic clade of Candida albicans (Q35007285) (← links)
- Antifungal drug resistance (Q35040008) (← links)
- Invasive oesophageal candidiasis: current and developing treatment options (Q35109119) (← links)
- Drug resistance in human pathogenic fungi (Q35376744) (← links)
- Activity of phenothiazines against medically important yeasts (Q35540629) (← links)
- Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans (Q35640149) (← links)
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo (Q35652874) (← links)
- Susceptibility testing of fungi: current status of the standardization process (Q35903839) (← links)
- An update on antifungal targets and mechanisms of resistance in Candida albicans (Q36235037) (← links)
- Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome (Q36528018) (← links)
- Candida albicans serotype analysis by flow cytometry. (Q36537515) (← links)
- Rapid susceptibility testing of fungi by flow cytometry using vital staining. (Q36542368) (← links)
- Antifungal Agents Used for Deep-Seated Mycotic Infections (Q36746886) (← links)
- Antifungal chemotherapy — Are we winning? (Q36882122) (← links)
- Application of DNA typing methods to epidemiology and taxonomy of Candida species (Q37139692) (← links)
- Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B (Q37202190) (← links)
- Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome (Q37210734) (← links)
- Comparison between methods for serotyping of Candida albicans produces discrepancies in results (Q37234720) (← links)
- Analysis of Candida albicans phenotypes from different geographical and anatomical sources. (Q37258061) (← links)
- Antifungals to treat Candida albicans (Q37763928) (← links)
- Candidiasis (Q38229535) (← links)
- The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans (Q39685110) (← links)
- Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media (Q39833505) (← links)
- Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents (Q39881200) (← links)
- Serotype prevalence of Candida albicans from blood culture isolates (Q40185025) (← links)
- Antifungal drug susceptibility testing. A critical review (Q40197570) (← links)
- Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts (Q40206965) (← links)
- Antifungal susceptibility testing (Q40795131) (← links)
- Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches (Q40878512) (← links)
- Update on invasive candidiasis (Q41188065) (← links)
- Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use (Q42929831) (← links)
- Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis. (Q43664192) (← links)
- Subgingival strains of Candida albicans in relation to geographical origin and occurrence of periodontal pathogenic bacteria (Q44142582) (← links)
- Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons. (Q46656032) (← links)
- Drug resistance in Candida albicans and Candida glabrata. (Q54394043) (← links)
- [Systemic candidiasis] (Q67979285) (← links)
- Chronic mucocutaneous candidiasis (Q69216250) (← links)